Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | GLS | O94925 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18854186 | 0.97 | CYP1A2 (0.34) | CYP1A2CES1CTDSP1CYP2C9NAMPT | |
| SCHEMBL18854185 | 0.78 | CYP1A2 (0.44) | CYP1A2CES1CTDSP1CYP2C9NAMPT | |
| SCHEMBL3079246 | 0.73 | CYP1A2 (0.47) | CYP1A2CES1CTDSP1CYP2C9NAMPT | |
| SCHEMBL655646 | 0.73 | KCNH2 (0.57) | CYP1A2CTDSP1KCNH2 | |
| SCHEMBL3030999 | 0.73 | CYP1A2 (0.39) | CYP1A2CES1CTDSP1HRH1KCNH2 | |
| SCHEMBL18596775 | 0.72 | KCNH2 (0.60) | CYP1A2CTDSP1HRH1KCNH2 | |
| SCHEMBL22308558 | 0.72 | KCNH2 (0.60) | CYP1A2CTDSP1HRH1KCNH2 | |
| SCHEMBL22307320 | 0.72 | KCNH2 (0.60) | CYP1A2CTDSP1HRH1KCNH2 | |
| SCHEMBL482984 | 0.72 | KCNH2 (0.60) | CYP1A2CTDSP1HRH1KCNH2 | |
| SCHEMBL31036061 | 0.72 | HRH1 (0.38) | CYP1A2CES1CTDSP1HRH1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9938267-B2 | Heterocyclic inhibitors of glutaminase | CALITHERA BIOSCIENCES, INC. (US) | 2018-04-10 | — | — | US | disclosed |